Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
18F-TPP PET/MR in Ventricular Arrhythmia
NCT03265431Phase 2Active, not recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jul 2017
- Primary completion
- Jun 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of BFPET in ventricular arrhythmia (VA) (3 arms), sponsored by Massachusetts General Hospital. Primary endpoint: TPP imaging in Ventricular Arrhythmia at 5 years. Started Jul 2017; status: active, not recruiting.
02
Drugs
BFPET
03
Conditions
ventricular arrhythmia (VA)
Beyond the preview
Go deeper on NCT03265431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03265431.